Genomic Testing

Latest News

Personalized therapeutic approaches in ccRCC remain challenging
Personalized therapeutic approaches in ccRCC remain challenging

April 15th 2024

"As a kidney cancer community, we need to investigate these molecular subtypes prospectively in clinical trials to determine whether specific subtypes benefit from certain therapies or not," says David A. Braun, MD, PhD.

Novel small activating RNA therapy explored in NMIBC
Novel small activating RNA therapy explored in NMIBC

April 12th 2024

Human kidney cross section on scientific background | Image Credit: © Crystal light - stock.adobe.com
Dr. Xu on why biomarkers are needed for individualized treatment approaches in RCC

April 5th 2024

Dr. Garje discusses mutations linked to more aggressive prostate cancer
Dr. Garje discusses mutations linked to more aggressive prostate cancer

April 3rd 2024

Trial launches of ctDNA-based blood test in urothelial carcinoma
Trial launches of ctDNA-based blood test in urothelial carcinoma

April 1st 2024

More News

© 2024 MJH Life Sciences

All rights reserved.